Overview
Watch a 30-minute webinar on RNAseq and its impact on advancing rare disease insights from Whole Exome Sequencing (WES) and Whole Genome Sequencing (WGS), led by Dr. Christine Eng, CMO, CQO, and Dr. Xiaonan Zhao, Associate Clinical Director at Baylor Genetics.
Please Share Your Feedback
Objectives
- Review the role of RNA sequencing in resolving variants of uncertain significance (VUS)
- Describe RNA sequencing and its ability to analyze splicing events
- Examine cases demonstrating the utility of RNA sequencing in VUS reclassification for WES & WGS